The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
When Will Generic Biologic Drugs Become Commercially Available?
Biosimilars are challenging to produce, but progress is being made
Rheumatology Drug Updates: Apremilast, Golimumab, and More
Information on new approvals and medication safety rheumatologists need to know
South Korea Okays First Officially Approved Monoclonal Antibody for RA
11 Products Looking for U.S. Marketing Nod
Biosimilar Drugs Face Challenges to Reach the U.S. Market
To date, the FDA has not approved a biosimilar product. In its own discussion of the merits and obstacles to biosimilar drugs, the ACR sponsored a panel session titled, “Biosimilar Products in the U.S. Market: Fact or Fiction?” at the 2011 ACR/ARHP Annual Scientific Meeting here in November.
- « Previous Page
- 1
- …
- 10
- 11
- 12